There’s still much more to come from the White House on tariffs, but the European Union has now reached a trade agreement ...

While it’s impossible to make apples-to-apples comparisons of the many obesity candidates with so many differences across ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

Krystal Biotech's decision follows the FDA’s rejection last month of Replimune’s RP1, which works similarly to Krystal ...

Vanda claims that two generics to its sleep disorder drug Hetlioz were approved despite inadequate data and is requesting ...

Dawnzera is the first and so far only RNA-targeting therapy approved as a prophylactic treatment for hereditary angioedema ...

The FDA has identified critical lapses at a production facility operated by Novo Nordisk that is used by several drugmakers, ...